EICHORCondition: Parkinson Disease · Dyskinesia, Drug-Induced · Dyskinesias · Sponsor: Addex Pharma S.A.
This open-label study is designed to assess the long-term safety and tolerability of dipraglurant in PD patients for up to 52 weeks (at doses of 150-300 mg per day) for patients that have completed an Addex sponsored double-blind clinical trial of dipraglurant.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Completed an Addex randomized controlled study of dipraglurant and, in the judgement of the Investigator, may benefit from open-label treatment * Able to take study drug 3 times daily and no less than 3 hours apart * Must be taking levodopa not less than 3 times daily throughout the study * Must maintain stable regimen of antiparkinson's medications (including levodopa) and be willing to continue the same doses and regimens for the first 4 weeks of the study Exclusion Criteria: * Patient is judged by the Investigator to be inappropriate for the study (for reasons such as, but not limited to, significant noncompliance in the Addex randomized controlled study of dipraglurant) * Use of amantadine or amantadine ER throughout the study * Use of memantine throughout the study * Any use of marijuana or other cannabis/cannabinoid products for the first 4 weeks of study participation Other protocol-defined inclusion and exclusion criteria may apply
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Augusta University | Augusta, Georgia, United States | — |
| University of Kansas Medical Center | Kansas City, Kansas, United States | — |
| Rutgers, the State University of New Jersey | New Brunswick, New Jersey, United States | — |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | — |
| The Ohio State University Wexner Medical Center | Columbus, Ohio, United States | — |
| Abington Neurologic Associates | Abington, Pennsylvania, United States | — |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | — |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05116813